Table of Contents
1. Liver cancer: current status of preclinical research2. Pancreatic cancer: current status of preclinical research
3. Heart cancer: current status of preclinical research
4. Bone cancer: current status of preclinical research
5. Spleen cancer: current status of preclinical research
6. ENT cancer: current status of preclinical research
7. Brain/CSN cancer: current status of preclinical research
8. Skin cancer: current status of preclinical research
9. Lung cancer: current status of preclinical research
10. Thorax cancer: current status of preclinical research
11. Thyroid cancer: current status of preclinical research
12. Kidney-adrenal cancer: current status of preclinical research
13. Urinary tracker cancer: current status of preclinical research
14. Breast cancer: current status of preclinical research
15. Blood cancer: current status of preclinical research
16. Prostate cancer: current status of preclinical research
17. Gynecologic cancer: current status of preclinical research
18. Stomach and intestinal cancer: current status of preclinical research
19. Plura and peritoneum cancer: current status of preclinical research
20. Ocular cancer: current status of preclinical research
21. Oral cancer: current status of preclinical research
22. Growth Inhibitory Effects of Unsaturated Linoleinic Acid with Conjugated Double Bonds for Colon Cancer Prevention
Authors
Ranjita Shegokar Postdoctoral Researcher, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Free University of Berlin, Germany.Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)
Yashwant Pathak Professor and Associate Dean, Faculty Affairs, College of Pharmacy, University of South Florida, Tampa, USA. Yashwant Pathak is a Professor and Associate Dean for faculty affairs at the Taneja College of Pharmacy at the University of South Florida, Tampa, USA. Prof. Pathak is also an Adjunct Professor at the Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia. His area of research is in health care education, nanotechnology, drug delivery systems, and nutraceuticals.
